150 related articles for article (PubMed ID: 34634948)
1. The Clinical Significance of RMI2 in Hepatocellular Carcinoma.
Zheng Ms B; Wang Ms H; Wang Ms JX; Liu Ms ZH; Zhang Md P; Zhang Md D
Technol Cancer Res Treat; 2021; 20():15330338211045496. PubMed ID: 34634948
[No Abstract] [Full Text] [Related]
2. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma.
Luo RZ; Cai PQ; Li M; Fu J; Zhang ZY; Chen JW; Cao Y; Yun JP; Xie D; Cai MY
PLoS One; 2014; 9(1):e85592. PubMed ID: 24475046
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
[TBL] [Abstract][Full Text] [Related]
7. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
8. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients.
Chen YL; Lin PY; Ming YZ; Huang WC; Chen RF; Chen PM; Chu PY
BMC Cancer; 2017 Jul; 17(1):474. PubMed ID: 28687090
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
10. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
11. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
12. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
13. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
14. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
[TBL] [Abstract][Full Text] [Related]
15. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
Liu W; Wang N; Lu M; Du XJ; Xing BC
Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
18. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
20. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
